1-4 of 4
James L. Labelle, MD, PhD
Close
Sort by
Journal Articles

Immune System Profiling Following Autologous Stem Cell Transplant for High-Risk Neuroblastoma Predicts Disease-Free Survival

Michele L Nassin, MD, Elitsa V Nicolaou, MD, Hillary M Hecktman, CPNP-AC, Caitlin W Cohen, CPNP-AC, Susan L Cohn, MD, John M Cunningham, MD, James L LaBelle, MD PhD
Journal: Blood
Blood (2016) 128 (22): 2251.
https://doi.org/10.1182/blood.V128.22.2251.2251
Published: 2016
Journal Articles

A Stapled BIM BH3 Helix Restores Apoptosis In Bim -Null Mantle Cell Lymphoma

Samuel G Katz, MD, PhD, James L Labelle, MD, PhD, Marina Godes, Jill Fisher, Gregory H. Bird, PhD, Loren D. Walensky, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 437.
https://doi.org/10.1182/blood.V116.21.437.437
Published: 2010
Journal Articles

A Stapled BIM BH3 Helix Overcomes the MCL-1-Mediated Apoptotic Blockade of Refractory Hematologic Cancers

James L. Labelle, MD, PhD, Chelsea E. Lawrence, Gregory H. Bird, Ph.D., Loren D. Walensky, M.D., Ph.D.
Journal: Blood
Blood (2008) 112 (11): 862.
https://doi.org/10.1182/blood.V112.11.862.862
Published: 2008
Journal Articles

Pharmacologic Replacement of BIM BH3 Reactivates Apoptosis in Hematologic Cancer and Lymphoproliferative Disease.

James L. LaBelle, MD, PhD, Jill K. Fisher, Samuel G. Katz, MD, PhD, Gregory H. Bird, PhD, Chelsea E. Lawrence, Amy M. Silverstein, Loren D. Walensky, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 524.
https://doi.org/10.1182/blood.V110.11.524.524
Published: 2007